Advances in the Treatment of Generalized Myasthenia Gravis: Which of Your Patients May Benefit from Targeted Immunotherapies?

Advances in the Treatment of Generalized Myasthenia Gravis: Which of Your Patients May Benefit from Targeted Immunotherapies? is organized by Med Learning Group.

Program Overview:
This enduring activity focuses on the treatment and management of patients with generalized myasthenia gravis (gMG).

Learning objectives:
On completing this program, attendees should be able to:
• Select appropriate treatments for patients with generalized MG based on their specific clinical characteristics
• Assess results from clinical trials evaluating emerging targeted therapies for the treatment of patients with generalized MG
• Predict the potential benefits of emerging targeted therapies for the treatment of generalized MG